- Release Date: 25/09/13 15:07
- Summary: GENERAL: CVT: Comvita Invests in World Class Honey Testing Facility
- Price Sensitive: No
- Download Document 3.54KB
CVT 25/09/2013 13:07 GENERAL REL: 1307 HRS Comvita Limited GENERAL: CVT: Comvita Invests in World Class Honey Testing Facility Global natural health and beauty products company Comvita is investing a further $1 million in a state of the art laboratory facility which will enable it to expand its testing and research capability for Manuka honey. Comvita CEO Brett Hewlett said, "We're investing in equipment that is the best available in the world and represents the highest levels of analytical performance. Developing a centre of excellence for honey testing will give us a leading edge when it comes to consumer confidence and trust in our products." "Our purchase of an Isotope Ratio Mass Spectrometer and a UHPLC with a Quantiva Mass Spectrometer detector means we will also be expanding the size of our laboratory and staffing. The Quantiva is the first of its type in New Zealand." "This investment will enable us to speed up the test result turnaround time and improve our ability to service our markets. It also provides us capability to develop additional tests as required for other products, and the equipment can also be used for research and development work." Mr. Hewlett said the recent scrutiny of the quality and safety of New Zealand food products means increased testing of honey to provide assurances to our global customers of freshness, purity, safety and authenticity has become essential. High level assurances of this nature are becoming a worldwide requirement and Comvita is committed to maintaining a leadership position in this regard. Manuka Honey quality standards Comvita is licensed to use the Unique Manuka Factor (UMF) quality mark, a system backed by an industry quality standard, independent audits and a network of accredited laboratories around the world. "Comvita was the first in the world to implement a new UPHLC laboratory method that detects in a single test for UMF, any effects of heat damage and the freshness of Manuka Honey. This rapid 3 in 1 test has given us enormous advantages in screening for the highest possible Manuka honey quality. We can provide assurances to our global customers that the quality is consistent and will remain so for the entire shelf-life of the product." Concern about food safety is a global phenomenon says Mr. Hewlett, and our decision to make this investment in our own testing facility will further strengthen our position as the world's leading manufacturer and marketer of Manuka honey. # Ends # For further information: Comvita Chief Operating Officer, Scott Coulter, 021 386 988 Comvita Chairman, Neil Craig, 021 731 509 Comvita Communications Manager, Julie Chadwick, 021 510 693 Background information About Comvita (www.comvita.co.nz) Comvita is an international natural health and beauty company committed to the development of innovative products, backed by credible scientific research. We are the global leader in Manuka (leptospermum) honey and fresh-picked Olive Leaf Extract, which are at the core of the Comvita product range. We have approximately 30% of honey supply under our ownership with the balance of supply from long term contractual and partnership arrangements. Comvita's Olive Leaf Extract is grown, harvested, extracted and bottled at the world's largest specialised olive leaf grove, with over 580,000 olive trees. Comvita sells into more than 18 countries through a network of wholesale and third-party outlets and online. We have offices in New Zealand, Australia, Hong Kong, Japan, Taiwan, South Korea and the United Kingdom. End CA:00241570 For:CVT Type:GENERAL Time:2013-09-25 13:07:06
- Forums
- NZX - By Stock
- Ann: GENERAL: CVT: Comvita Invests in World Class
CVT
comvita limited
Add to My Watchlist
5.17%
!
55.0¢

Ann: GENERAL: CVT: Comvita Invests in World Class
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.